Canntab Therapeutics Limited Share Price

Equities

CTABF

CA1377991023

Pharmaceuticals

Delayed OTC Markets 07:18:25 27/06/2024 pm IST 5-day change 1st Jan Change
0.002 USD -77.01% Intraday chart for Canntab Therapeutics Limited 0.00% -78.02%
Current month-77.01%
1 month-77.01%
Sales 2021 - Sales 2022 0.29 24.46 Capitalization 9.99M 833M
Net income 2021 -4M -334M Net income 2022 -3M -250M EV / Sales 2021 -
Net Debt 2021 75.05K 6.26M Net Debt 2022 1.15M 95.83M EV / Sales 2022 3,79,69,265 x
P/E ratio 2021
-7.9 x
P/E ratio 2022
-2.63 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 86.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-77.01%
Current month-77.01%
1 month-77.01%
3 months-77.01%
6 months-78.02%
Current year-78.02%
More quotes
1 month
0.00
Extreme 0.002
0.01
Current year
0.00
Extreme 0.0016
0.01
1 year
0.00
Extreme 0.0016
0.01
3 years
0.00
Extreme 0.0016
0.71
5 years
0.00
Extreme 0.0016
0.89
10 years
0.00
Extreme 0.0016
1.64
More quotes
Date Price Change Volume
27/24/27 0.002 -77.01% 659
18/24/18 - +-NaN% 9

Delayed Quote OTC Markets, June 27, 2024 at 07:18 pm IST

More quotes
Canntab Therapeutics Limited is a Canadian phytopharmaceutical company focused on the manufacturing and distribution of a suite of hard pill cannabinoid formulations in multiple doses and timed-release combinations. The Company’s operations comprise a single segment engaged in the medical marijuana business. The Company’s hard pill cannabinoid formulations provide doctors, patients, and consumers with medical grade solutions. These include once a day and extended-release formulations. Its products include INSTANT RELEASE - (IR Tablet), EXTENDED-RELEASE - (XR Tablet), and ORAL DISSOLVING - O.D. Tablet (ODT). The IR Tablet is a release profile for solid hard tablets. The XR Tablet is a phytocannabinoid vehicle that is designed to directly address the drawbacks and challenges of competing oral delivery systems. ODT is specifically designed to dissolve directly in the patient’s mouth, with an onset of action between five and thirty minutes.
More about the company